Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

TEM

Tempus AI Inc

Nov 06 • 03:31PM ET

73.13

-9.13 -11.10 %

Healthcare • Health Information Services • USA • NASD

Peers: ILMN EXAS GH TXG CRSP PACB NTLA EDIT CDNA TWST

| Held by: ARKK VTI VB ARKG VBK VXF BAI IBB IWP JTEK

Index	-	P/E	-	EPS (ttm)	-1.18	Insider Own	44.41%	Shs Outstand	172.63M	Perf Week	-15.23%
Market Cap	12.70B	Forward P/E	-	EPS next Y	-0.43	Insider Trans	-2.76%	Shs Float	96.58M	Perf Month	-29.17%
Enterprise Value	13.28B	PEG	-	EPS next Q	-0.06	Inst Own	43.45%	Short Float	22.91%	Perf Quarter	20.14%
Income	-203.88M	P/S	11.50	EPS this Y	59.24%	Inst Trans	7.01%	Short Ratio	2.37	Perf Half Y	12.13%
Sales	1.11B	P/B	25.59	EPS next Y	33.43%	ROA	-12.53%	Short Interest	22.13M	Perf YTD	116.62%
Book/sh	2.86	P/C	16.73	EPS next 5Y	-	ROE	-72.61%	52W High	104.32 -29.90%	Perf Year	47.74%
Cash/sh	4.37	P/FCF	-	EPS past 3/5Y	-37.97% -32.48%	ROIC	-11.13%	52W Low	31.36 133.20%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	39.06% 38.58%	Gross Margin	60.33%	Volatility	5.65% 6.41%	Perf 5Y	-
Dividend TTM	-	EV/Sales	12.02	EPS Y/Y TTM	76.81%	Oper. Margin	-21.07%	ATR (14)	5.77	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.12	Sales Y/Y TTM	72.58%	Profit Margin	-18.45%	RSI (14)	34.45	Recom	2.06
Dividend Gr. 3/5Y	- -	Current Ratio	3.28	EPS Q/Q	0.15%	SMA20	-17.19%	Beta	4.97	Target Price	91.92
Payout	-	Debt/Eq	2.63	Sales Q/Q	84.72%	SMA50	-14.93%	Rel Volume	1.09	Prev Close	82.26
Employees	2400	LT Debt/Eq	2.61	Earnings	Nov 04 AMC	SMA200	10.76%	Avg Volume	9.32M	Price	73.13
IPO	Jun 14, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	36.16% 1.67%	Trades		Volume	9,458,648	Change	-11.10%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-21-25	Downgrade	TD Cowen	Buy → Hold	$88
Oct-20-25	Initiated	Canaccord Genuity	Buy	$110
Sep-02-25	Initiated	H.C. Wainwright	Buy	$90
Apr-21-25	Initiated	BTIG Research	Buy	$60
Feb-25-25	Downgrade	JP Morgan	Overweight → Neutral	$50 → $55
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-05-25	Resumed	TD Cowen	Buy	$58 → $74
Dec-13-24	Initiated	Wolfe Research	Outperform	$60
Dec-09-24	Initiated	Guggenheim	Buy	$74
Nov-11-24	Downgrade	Stifel	Buy → Hold	$45 → $65
Oct-02-24	Downgrade	BofA Securities	Buy → Neutral	$45 → $60
Aug-12-24	Initiated	Piper Sandler	Neutral	$40
Jul-09-24	Initiated	William Blair	Outperform
Jul-09-24	Initiated	TD Cowen	Buy	$50
Jul-09-24	Initiated	Stifel	Buy	$45
Jul-09-24	Initiated	Needham	Buy	$47
Jul-09-24	Initiated	Morgan Stanley	Overweight	$44
Jul-09-24	Initiated	Loop Capital	Buy	$48
Jul-09-24	Initiated	Longbow	Buy	$48
Jul-09-24	Initiated	JP Morgan	Overweight	$42

Show Previous Ratings

Today 01:22PM	Tempus AI: Volatility Equates to Opportunity in AI Leader (MarketBeat) -11.10%
Nov-05-25 11:01AM	TEM's Q3 Earnings & Revenues Beat, Stock Down in After-Market Hours (Zacks)
08:30AM	Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025 (Business Wire)
05:25AM	3 Growth Stocks to Invest $1,000 in Right Now (Motley Fool)
12:07AM	Tempus AI Inc (TEM) Q3 2025 Earnings Call Highlights: Strong Genomics Growth and Strategic ... (GuruFocus.com)
06:30PM	Loading…
Nov-04-25 06:30PM	Tempus (TEM) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
05:45PM	Tempus AI (TEM) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Tempus Reports Third Quarter 2025 Results (Business Wire)
06:01AM	Sex Dolls, Boycotts, Protests: Furor in France as Shein Opens Paris Store (The Wall Street Journal)
Nov-03-25 04:36PM	Sex Dolls, Boycotts, Protests: Furor in France as Shein Opens Paris Store (The Wall Street Journal)
07:19AM	Tempus AI Inc (TEM) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-31-25 10:46AM	This AI Health Stock is Up Over 150% This Yearand Its Not Slowing Down (24/7 Wall St.)
Oct-30-25 07:45AM	Omnicell (OMCL) Q3 Earnings and Revenues Surpass Estimates (Zacks)
Oct-29-25 08:57AM	TEM vs. EXAS: Which Genomics Player Offers Greater Upside? (Zacks)
Oct-28-25 08:30AM	Tempus to Participate in the Stifel 2025 Healthcare Conference (Business Wire) -5.45%
05:53AM	Loading…
05:53AM	Tempus AI (TEM) Stock Gets a $110 Price Target on Rising AI Adoption in Medicine (Insider Monkey)
Oct-27-25 09:20AM	Tempus AI Enhances AI-Driven Diagnostics With Multiple FDA Approvals (Zacks)
Oct-21-25 09:47AM	Tempus AI valuation catches up with its growth, says TD Cowen downgrading stock (Investing.com)
09:32AM	Goldman downgraded, Coinbase initiated: Wall Street's top analyst calls (The Fly)
08:30AM	Tempus to Report Third Quarter 2025 Financial Results on November 4 (Business Wire)
Oct-20-25 06:36PM	Why Tempus AI Stock Raced More Than 5% Higher Today (Motley Fool) +5.32%
04:56PM	These Stocks Moved the Most Today: Apple, Amazon, TSMC, Cleveland-Cliffs, Super Micro, Cooper Cos., Tesla, Netflix, and More (Barrons.com)
09:34AM	Apple upgraded, Rivian downgraded: Wall Street's top analyst calls (The Fly)
09:03AM	Tempus AI Stock Before Q3 Earnings Release: To Buy or Not to Buy? (Zacks)
09:00AM	Ambry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity (Business Wire)
Oct-17-25 09:45AM	Tempus AI Fuels Growth Through Strategic Biotech Collaborations (Zacks)
Oct-16-25 12:36PM	Hims & Hers Elevates Technology-Driven Healthcare Accessibility (Zacks)
08:30AM	Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research (Business Wire)
Oct-15-25 01:49PM	Tempus AI Hits $100-Are Shares Due for a Pullback? (MarketBeat)
08:30AM	Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025 (Business Wire)
03:00PM	Loading…
Oct-14-25 03:00PM	NVDA & PLTR Driving AI in Health: Top Health IT Stocks for Q3 Earnings (Zacks)
Oct-10-25 08:44AM	TEM Expands Partnership With Northwestern Medicine Amid AI Boom (Zacks)
Oct-09-25 10:54AM	Strategic Deals Drive TEM Growth Amid Competition: Buy, Hold or Sell? (Zacks)
08:30AM	Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy (Business Wire)
Oct-08-25 05:48PM	These 5 Beaten-Down Tech Stocks Could Catch Fire Next (MarketBeat) +11.01%
11:22AM	Tempus AI, Inc. (TEM): A Bull Case Theory (Insider Monkey)
10:58AM	Breakthrough Discoveries Unlock $643B Cancer Treatment Market By 2034 (PR Newswire)
Oct-05-25 02:42AM	Tempus AI, Inc. (TEM) Secures FDA Clearance for xR IVD Device to Enhance Drug Discovery (Insider Monkey)
Oct-03-25 05:30AM	Why Tempus AI Stock Was Motoring Higher This Week (Motley Fool)
Oct-01-25 12:24PM	Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density (Business Wire) +9.02%
Sep-27-25 11:13AM	3 Healthcare Stocks Using AI to Drive Growth (MarketBeat)
08:45AM	What Are 2 Great Tech Stocks to Buy Right Now? (Motley Fool)
Sep-26-25 09:21AM	TEM vs. ILMN: Which Precision Oncology Stock Is Worth Buying Now? (Zacks)
Sep-25-25 06:53PM	Why Tempus AI Stock Is Plunging This Week (Motley Fool)
Sep-23-25 08:32AM	Tempus AI Enhances Cancer Research Tools With FDA-Cleared xR IVD (Zacks)
Sep-22-25 04:07PM	IBD 50's Tempus AI Pulls Back From Record High After Another FDA Clearance (Investor's Business Daily)
12:45PM	Hims & Hers Expands Care Ecosystem via Global and Digital Innovation (Zacks)
10:04AM	IBD 50's Tempus AI Hits Record High On Yet Another FDA Clearance (Investor's Business Daily)
09:00AM	3 Big Short Interest Names with Bullish Setups (MarketBeat)
08:30AM	Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device (Business Wire)
Sep-21-25 09:30AM	Tempus AI Surges Since IPO as FDA Clearance Boosts Growth Outlook (Insider Monkey)
Sep-18-25 08:45AM	Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises (PR Newswire)
Sep-16-25 08:20AM	TEM Strengthens Radiology Portfolio With Pixel's FDA Clearance (Zacks)
Sep-15-25 08:00AM	Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease (PR Newswire)
Sep-12-25 09:42AM	Tempus AI (TEM) Touches 7-Month High on Pixel FDA Approval (Insider Monkey)
08:43AM	Tempus (TEM) Stock Jumps 13.6%: Will It Continue to Soar? (Zacks)
Sep-11-25 06:26PM	Why Tempus AI Stock Soared Nearly 14% Higher Today (Motley Fool) +13.59%
05:01PM	Northwestern Medicine Integrates Tempus AI's "David" Clinical Assistant into EHR Platform (Insider Monkey)
01:58PM	Tempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac Imaging (Benzinga)
11:11AM	Tempus AI Surges, Flirting With A Profit-Taking Zone, On A Fresh FDA Move (Investor's Business Daily)
08:35AM	TEM Gains Validation for PurIST Amid Evolving Cancer Care Landscape (Zacks)
08:30AM	Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device (Business Wire)
Sep-09-25 08:44AM	TEM Q2 Revenues Soar Amid Coverage Issues: Time to Buy, Hold or Sell? (Zacks)
08:30AM	Tempus Announces New Study in JCO Precision Oncology Validating PurIST Algorithm for Enhanced Therapy Selection in Pancreatic Cancer (Business Wire)
Sep-04-25 12:30PM	What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum? (Zacks)
08:30AM	Northwestern Medicine Becomes First Health System to Integrate Tempus' Generative AI Co-Pilot, David, Into Its EHR Platform (Business Wire)
Sep-03-25 04:01PM	Tempus to Participate in Morgan Stanleys 23rd Annual Global Healthcare Conference (Business Wire)
Sep-02-25 10:40AM	3 Heavily Shorted Stocks That Could Prove the Bears Wrong (MarketBeat)
09:45AM	Elf Beauty downgraded, Zscaler upgraded: Wall Street's top analyst calls (The Fly)
Aug-29-25 11:42PM	Tempus AI, Inc. (TEM) Expands into Digital Pathology with Paige Acquisition (Insider Monkey)
04:36PM	Tempus AI Stock Required A Tempered Position (Investor's Business Daily)
Aug-27-25 10:44AM	Hims & Hers Scales Growth Through Subscriptions and Care Expansion (Zacks)
Aug-26-25 08:42AM	Tempus' Key Acquisitions Strengthen Its AI Healthcare Leadership (Zacks)
06:00AM	Tempus inks $81M Paige buyout to support AI model development (MedTech Dive)
Aug-25-25 03:00PM	Tempus AI or Butterfly: Which AI Health Tech Stock is a Buy Now? (Zacks) -5.74%
10:30AM	BC-Most Active Stocks (Associated Press Finance)
09:12AM	Zacks Market Edge Highlights: ARKK, Tesla, Palantir Technologies, Robinhood Markets and Tempus (Zacks)
05:02AM	Tempus to acquire AI digital pathology company Paige (Medical Device Network)
12:21AM	TD Cowen Lifts Tempus AI (TEM) Price Target on Genomic Volumes Growth (Insider Monkey)
Aug-23-25 04:00AM	The Next Big Thing: 2 AI-Powered Healthcare Stocks Ready to Explode (Motley Fool)
Aug-22-25 02:38PM	Tempus AI Expands Into Digital Pathology With Paige Acquisition (Benzinga)
09:20AM	Tempus Announces the Acquisition of Paige (Business Wire)
08:02AM	4 Medical Devices Behemoths to Buy Amid Extensive AI Applications (Zacks)
Aug-21-25 07:11PM	Cathie Wood's ARKK ETF is Back: Buy It or Not? (Zacks)
Aug-20-25 11:47AM	5 High Short-Interest Stocks to Buy Before November (MarketBeat)
Aug-19-25 09:33AM	Strategic Partnerships Power Tempus AI's Healthcare Expansion (Zacks) -6.85%
Aug-18-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +6.33%
Aug-16-25 07:00AM	MarketBeat Week in Review - 08/11 - 08/15 (MarketBeat)
Aug-14-25 02:54PM	Tempus AI Stock Scores Relative Strength Rating Upgrade (Investor's Business Daily)
08:07AM	Webtoon, Carlsberg, Tempus: Trending Stocks (Yahoo Finance Video)
08:00AM	Dow Jones Futures: Is Stock Market Rotating? This Cathie Wood, Nancy Pelosi Pick Is A Buy (Investor's Business Daily)
Aug-13-25 04:39PM	Tempus AI's Strong Q2 Fuels Growth Story-More Upside Ahead? (MarketBeat)
03:00PM	Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold? (Zacks)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
08:37AM	TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move? (Zacks)
Aug-11-25 10:30AM	BC-Most Active Stocks (Associated Press Finance)
Aug-09-25 03:04AM	Tempus AI Inc (TEM) Q2 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Advances (GuruFocus.com)
Aug-08-25 06:42PM	Why Tempus AI Stock Jumped Today (Motley Fool)
12:19PM	Gold hits new high, altcoins stocks rally, Tempus AI Q2 beat (Yahoo Finance Video)
09:30AM	Compared to Estimates, Tempus (TEM) Q2 Earnings: A Look at Key Metrics (Zacks)

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Fukushima Ryan	Chief Operating Officer	Nov 03 '25	Sale	89.03	5,000	445,160	125,000	Nov 05 04:15 PM
Epstein David R	Director	Nov 03 '25	Sale	90.00	370	33,300	26,671	Nov 05 04:15 PM
VANESSA L KUBO	Officer	Nov 03 '25	Proposed Sale	89.85	20,000	1,797,000		Nov 03 04:26 PM
DAVID R. EPSTEIN	Director	Nov 03 '25	Proposed Sale	89.85	990	88,952		Nov 03 04:25 PM
LEFKOFSKY ERIC P	CEO and Chairman	Oct 28 '25	Sale	89.11	332,500	29,629,006	9,074,532	Oct 30 04:31 PM
Eric Lefkofsky	Officer	Oct 28 '25	Proposed Sale	91.58	332,500	30,450,350		Oct 28 04:09 PM
Fukushima Ryan	Chief Operating Officer	Oct 06 '25	Sale	92.32	5,000	461,606	130,000	Oct 08 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Sep 25 '25	Sale	76.56	332,500	25,457,014	9,141,032	Sep 29 04:33 PM
Eric Lefkofsky	Officer	Sep 25 '25	Proposed Sale	84.13	332,500	27,973,225		Sep 25 07:04 PM
Fukushima Ryan	Chief Operating Officer	Sep 02 '25	Sale	75.80	10,000	758,028	135,000	Sep 04 04:15 PM
Epstein David R	Director	Sep 02 '25	Sale	73.64	250	18,410	27,041	Sep 04 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Aug 27 '25	Sale	74.10	332,500	24,637,581	9,207,533	Aug 29 05:13 PM
Leonsis Theodore	Director	Aug 26 '25	Sale	75.83	20,000	1,516,600	66,756	Aug 28 04:15 PM
Eric Lefkofsky	Officer	Aug 27 '25	Proposed Sale	75.90	332,500	25,236,750		Aug 27 04:19 PM
Leonsis Theodore	Director	Aug 26 '25	Proposed Sale	75.83	20,000	1,516,650		Aug 26 01:27 PM
Polovin Andrew	EVP and General Counsel	Aug 19 '25	Sale	74.65	5,398	402,982	132,056	Aug 21 04:15 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Aug 19 '25	Sale	74.65	3,664	273,532	94,115	Aug 21 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Aug 19 '25	Sale	74.65	17,458	1,303,307	2,020,042	Aug 21 04:15 PM
Fukushima Ryan	Chief Operating Officer	Aug 19 '25	Sale	74.65	17,460	1,303,456	839,180	Aug 21 04:15 PM
Rogers James William	Chief Financial Officer	Aug 19 '25	Sale	74.65	7,528	561,994	138,473	Aug 21 04:15 PM
Bartolucci Ryan M	Chief Accounting Officer	Aug 19 '25	Sale	74.65	1,904	142,141	45,895	Aug 21 04:15 PM
Erik Phelps	Officer	Aug 19 '25	Proposed Sale	78.45	3,664	287,441		Aug 20 07:19 AM
Andrew Polovin	Officer	Aug 19 '25	Proposed Sale	78.45	5,398	423,473		Aug 20 07:17 AM
Ryan Fukushima	Officer	Aug 19 '25	Proposed Sale	78.45	17,460	1,369,737		Aug 20 07:15 AM
Eric Paul Lefkofsky	Officer	Aug 19 '25	Proposed Sale	78.45	17,458	1,369,580		Aug 20 07:14 AM
James William Rogers	Officer	Aug 19 '25	Proposed Sale	78.45	7,528	590,572		Aug 19 09:59 PM
Ryan M. Bartolucci	Officer	Aug 19 '25	Proposed Sale	78.45	1,904	149,369		Aug 19 09:56 PM
Leonsis Theodore	Director	Aug 13 '25	Proposed Sale	69.90	44,000	3,075,786		Aug 18 02:44 PM
Leonsis Theodore	Director	Aug 13 '25	Sale	69.90	44,000	3,075,600	86,756	Aug 15 09:21 PM
Epstein David R	Director	Aug 01 '25	Sale	55.16	370	20,409	27,291	Aug 05 04:15 PM
DAVID R. EPSTEIN	Director	Aug 01 '25	Proposed Sale	56.59	620	35,086		Aug 01 04:30 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jul 28 '25	Sale	62.87	166,250	10,452,027	9,274,033	Jul 30 08:42 PM
Eric Lefkofsky	Officer	Jul 28 '25	Proposed Sale	64.49	166,250	10,721,462		Jul 28 04:13 PM
Fukushima Ryan	Chief Operating Officer	Jul 07 '25	Sale	60.00	5,000	300,000	145,000	Jul 09 04:15 PM
VANESSA L KUBO	Officer	Jul 07 '25	Proposed Sale	60.97	20,000	1,219,400		Jul 07 04:16 PM
Doudna Jennifer A	Director	Jul 01 '25	Sale	62.52	625	39,075	26,554	Jul 03 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jun 17 '25	Sale	70.07	250,000	17,516,593	9,357,283	Jun 20 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jun 18 '25	Sale	69.44	250,000	17,359,469	9,307,283	Jun 20 04:15 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Jun 16 '25	Sale	72.56	51,317	3,723,634	97,779	Jun 18 04:15 PM
Polovin Andrew	EVP and General Counsel	Jun 16 '25	Sale	72.13	1,423	102,641	137,454	Jun 18 04:15 PM
Eric Paul Lefkofsky	Officer	Jun 17 '25	Proposed Sale	72.00	400,000	28,800,000		Jun 17 09:45 PM
ERIK PHELPS	Officer	Jun 16 '25	Proposed Sale	71.28	51,317	3,657,876		Jun 16 04:30 PM
ANDREW POLOVIN	Officer	Jun 16 '25	Proposed Sale	71.28	1,423	101,431		Jun 16 04:22 PM
Leonsis Theodore	Director	Jun 11 '25	Sale	67.66	205,847	13,927,976	0	Jun 13 04:15 PM
Revolution Growth Management C	Shareholder	Jun 11 '25	Proposed Sale	69.38	205,847	14,281,665		Jun 11 04:02 PM
Fukushima Ryan	Chief Operating Officer	Jun 03 '25	Sale	62.29	20,000	1,245,764	856,640	Jun 05 04:15 PM
Doudna Jennifer A	Director	Jun 02 '25	Sale	55.20	558	30,802	27,179	Jun 04 04:15 PM
Epstein David R	Director	Jun 02 '25	Sale	55.20	250	13,800	27,661	Jun 04 04:15 PM
JENNIFER A DOUDNA	Director	Jun 02 '25	Proposed Sale	55.18	1,183	65,278		Jun 02 04:32 PM
Rogers James William	Chief Financial Officer	May 20 '25	Sale	63.27	23,121	1,462,809	146,001	May 22 08:00 PM
Polovin Andrew	EVP and General Counsel	May 20 '25	Sale	63.43	17,552	1,113,385	138,877	May 22 08:00 PM
Phelps Erik	EVP & Chief Admin & Legal Off	May 20 '25	Sale	63.21	8,415	531,918	149,096	May 22 08:00 PM
LEFKOFSKY ERIC P	CEO and Chairman	May 20 '25	Sale	63.21	16,752	1,058,905	4,878,837	May 22 08:00 PM
Fukushima Ryan	Chief Operating Officer	May 20 '25	Sale	63.21	7,820	494,308	876,640	May 22 08:00 PM
Bartolucci Ryan M	Chief Accounting Officer	May 20 '25	Sale	63.23	6,073	384,023	47,799	May 22 08:00 PM
Ryan M. Bartolucci	Officer	May 20 '25	Proposed Sale	63.74	4,254	271,150		May 21 07:39 PM
Ryan Fukushima	Officer	May 20 '25	Proposed Sale	63.74	7,820	498,447		May 21 07:36 PM
Andrew Polovin	Officer	May 20 '25	Proposed Sale	63.74	9,797	624,461		May 21 07:25 PM
Eric Paul Lefkofsky	Officer	May 20 '25	Proposed Sale	63.74	16,752	1,067,772		May 21 07:23 PM
Erik Phelps	Officer	May 20 '25	Proposed Sale	63.74	8,415	536,372		May 21 07:20 PM
James William Rogers	Officer	May 20 '25	Proposed Sale	63.74	11,413	727,465		May 21 07:18 PM
RYAN BARTOLUCCI	Officer	May 20 '25	Proposed Sale	63.74	1,819	115,943		May 20 04:32 PM
ANDREW POLOVIN	Officer	May 20 '25	Proposed Sale	63.74	7,755	494,304		May 20 04:31 PM
JAMES ROGERS	Officer	May 20 '25	Proposed Sale	63.74	11,708	746,268		May 20 04:31 PM
Leonsis Theodore	Director	May 09 '25	Sale	66.26	770	51,020	43,550	May 13 04:15 PM
REVOLUTION GROWTH III, LP	Shareholder	May 09 '25	Proposed Sale	65.22	770	50,219		May 09 04:18 PM
Fukushima Ryan	Chief Operating Officer	May 06 '25	Sale	52.36	20,000	1,047,239	884,460	May 08 04:30 PM
Epstein David R	Director	May 01 '25	Sale	53.50	370	19,795	25,914	May 05 04:15 PM
Gottlieb Scott	Director	Apr 01 '25	Sale	47.21	27,837	1,314,154	32,839	Apr 03 05:30 PM
Doudna Jennifer A	Director	Apr 01 '25	Sale	48.12	625	30,075	25,740	Apr 03 04:15 PM
Fukushima Ryan	Chief Operating Officer	Apr 01 '25	Sale	47.20	20,000	944,085	904,460	Apr 03 04:15 PM
Frederick Wayne A.I.	Director	Mar 31 '25	Sale	45.54	3,000	136,620	26,514	Apr 02 06:13 PM
RYAN FUKUSHIMA	Officer	Apr 01 '25	Proposed Sale	48.24	60,000	2,894,400		Apr 01 04:22 PM
Polovin Andrew	EVP and General Counsel	Mar 21 '25	Sale	50.00	3,076	153,800	151,095	Mar 25 04:15 PM
ANDREW POLOVIN	Officer	Mar 21 '25	Proposed Sale	48.04	3,076	147,771		Mar 21 04:21 PM
Rogers James William	Chief Financial Officer	Mar 18 '25	Sale	45.97	23,030	1,058,699	164,750	Mar 19 06:30 PM
Polovin Andrew	EVP and General Counsel	Mar 18 '25	Sale	45.98	13,135	603,970	154,171	Mar 19 06:30 PM
Epstein David R	Director	Mar 17 '25	Sale	46.83	990	46,362	26,284	Mar 19 06:30 PM
West Nadja	Director	Mar 17 '25	Sale	48.86	7,634	372,962	30,071	Mar 19 06:30 PM
Gottlieb Scott	Director	Mar 17 '25	Sale	48.85	27,838	1,359,989	60,676	Mar 19 06:30 PM
Frederick Wayne A.I.	Director	Mar 17 '25	Sale	48.85	9,000	439,659	29,514	Mar 19 06:30 PM
Doudna Jennifer A	Director	Mar 17 '25	Sale	48.80	9,308	454,210	26,365	Mar 19 06:30 PM
ANDREW POLOVIN	Officer	Mar 18 '25	Proposed Sale	49.87	13,135	655,042		Mar 18 04:41 PM
JAMES ROGERS	Officer	Mar 18 '25	Proposed Sale	49.87	23,030	1,148,506		Mar 18 04:27 PM
WAYNE FREDERICK	Director	Mar 17 '25	Proposed Sale	47.17	12,000	566,040		Mar 17 04:47 PM
DAVID R. EPSTEIN	Director	Mar 17 '25	Proposed Sale	47.17	1,610	75,944		Mar 17 04:25 PM
SCOTT GOTTLIEB	Director	Mar 17 '25	Proposed Sale	47.17	55,675	2,626,190		Mar 17 04:23 PM
LEFKOFSKY ERIC P	CEO and Chairman	Mar 05 '25	Sale	50.93	562,345	28,641,725	9,457,283	Mar 07 04:56 PM
LEFKOFSKY ERIC P	CEO and Chairman	Mar 06 '25	Sale	49.83	250,000	12,457,454	9,407,283	Mar 07 04:56 PM
Fukushima Ryan	Chief Operating Officer	Mar 04 '25	Sale	51.15	20,000	1,022,974	924,460	Mar 06 05:05 PM
West Nadja	Director	Mar 04 '25	Sale	51.11	809	41,347	37,705	Mar 06 05:05 PM
Eric P. Lefkofsky	Officer	Mar 05 '25	Proposed Sale	52.73	662,345	34,925,452		Mar 05 05:44 PM
Doudna Jennifer A	Director	Mar 03 '25	Sale	57.52	338	19,442	35,673	Mar 05 04:15 PM
Epstein David R	Director	Mar 03 '25	Sale	57.52	250	14,380	27,274	Mar 05 04:15 PM
NADJA WEST	Director	Mar 04 '25	Proposed Sale	50.93	8,443	430,002		Mar 04 05:08 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 27 '25	Sale	58.75	3,240,234	190,363,748	0	Feb 27 07:39 PM
Lightbank Investments 1B, LLC	Affiliate	Feb 27 '25	Proposed Sale	59.10	115,751	6,840,884		Feb 27 04:27 PM
Innovation Group Investors, L.	Affiliate	Feb 27 '25	Proposed Sale	59.10	1,580,928	93,432,845		Feb 27 04:26 PM
Lightbank Global, LLC	Affiliate	Feb 27 '25	Proposed Sale	59.10	1,397,589	82,597,510		Feb 27 04:25 PM
Innovation Group Investors, L.	Affiliate	Feb 27 '25	Proposed Sale	59.10	145,966	8,626,591		Feb 27 04:24 PM

Open in Screener

PFE

Pfizer Inc

Nov 06 • 03:31PM ET

24.92

+0.31 1.24 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO IVV SPY VTV XLV VYM VHT DVY FDL

Index	S&P 500	P/E	14.52	EPS (ttm)	1.72	Insider Own	0.11%	Shs Outstand	5.69B	Perf Week	2.58%
Market Cap	141.67B	Forward P/E	7.93	EPS next Y	3.14	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	-2.97%
Enterprise Value	188.69B	PEG	-	EPS next Q	0.66	Inst Own	66.94%	Short Float	2.06%	Perf Quarter	1.37%
Income	9.80B	P/S	2.26	EPS this Y	0.64%	Inst Trans	-0.95%	Short Ratio	2.10	Perf Half Y	8.47%
Sales	62.78B	P/B	1.53	EPS next Y	0.41%	ROA	4.58%	Short Interest	116.82M	Perf YTD	-6.08%
Book/sh	16.32	P/C	9.45	EPS next 5Y	-0.56%	ROE	10.59%	52W High	27.99 -10.98%	Perf Year	-10.24%
Cash/sh	2.64	P/FCF	13.65	EPS past 3/5Y	-28.69% -13.27%	ROIC	6.52%	52W Low	20.92 19.13%	Perf 3Y	-48.10%
Dividend Est.	1.70 (6.81%)	EV/EBITDA	7.22	Sales past 3/5Y	-7.84% 9.10%	Gross Margin	69.12%	Volatility	2.46% 1.82%	Perf 5Y	-25.90%
Dividend TTM	1.71 (6.86%)	EV/Sales	3.01	EPS Y/Y TTM	128.96%	Oper. Margin	30.99%	ATR (14)	0.50	Perf 10Y	-24.38%
Dividend Ex-Date	Nov 07, 2025	Quick Ratio	0.97	Sales Y/Y TTM	4.44%	Profit Margin	15.60%	RSI (14)	52.95	Recom	2.46
Dividend Gr. 3/5Y	2.49% 2.97%	Current Ratio	1.28	EPS Q/Q	-20.96%	SMA20	1.32%	Beta	0.42	Target Price	28.61
Payout	120.11%	Debt/Eq	0.66	Sales Q/Q	-5.92%	SMA50	0.69%	Rel Volume	1.86	Prev Close	24.61
Employees	81000	LT Debt/Eq	0.62	Earnings	Nov 04 BMO	SMA200	1.14%	Avg Volume	55.61M	Price	24.92
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	37.53% 0.94%	Trades		Volume	95,936,960	Change	1.24%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60

Show Previous Ratings

Today 03:23PM	Novo Nordisk challenges Pfizer to raise offer for obesity biotech Metsera (Financial Times)
03:03PM	Stocks to Watch Thursday: Marvell, Arm, Snap, DraftKings (The Wall Street Journal)
03:02PM	Biotech M&A Deals Are Trickier Than They Look. Watch the Milestone Payments. (Barrons.com)
01:34PM	Novo Nordisk and Eli Lilly Can Sell Their Weight-Loss Drugs to Medicare Market (Barrons.com)
02:20PM	Jim Cramer Highlights the Woes of Pfizer and the Drug Sector (Insider Monkey)
10:14AM	Loading…
10:14AM	'It's Getting Ugly,' Analyst Says As Pfizer Escalates Its Gloves-Off Fight For Metsera (Investor's Business Daily)
12:36PM	No Brainer Dividend Stocks To Buy Now (24/7 Wall St.)
12:05PM	Lilly, Novo to Lower Obesity Drug Prices in Deal With Trump (Bloomberg)
11:58AM	Moderna Q3 Earnings Beat, Stock Up on Revised '25 Spending Plans (Zacks)
11:45AM	AZN Q3 Earnings Top Estimates, Sales Rise As Most Key Drugs Outperform (Zacks)
11:16AM	Modernas Quarter Wasnt As Bad as It Could Have Been. The Stock Is Up. (Barrons.com)
10:46AM	ESPN & Penn end pact, Metsera bidding war, Boeing case dismissed (Yahoo Finance Video)
08:09AM	Earnings live: Moderna stock pops amid cost-cutting efforts, Snap stock soars, Duolingo plunges (Yahoo Finance)
07:51AM	AstraZeneca CEO bullish on record revenue numbers and US growth (Yahoo Finance Video)
07:29AM	Moderna Swings to a Loss. The Stock Jumps Anyway. (Barrons.com)
04:44AM	Loading…
04:44AM	Why Pfizer's 7%-Yielding Dividend Just Became Safer -- and More Tempting (Motley Fool)
04:10AM	2 Dirt Cheap Stocks to Buy With $1,000 Right Now (Motley Fool)
Nov-05-25 06:13PM	Expect Pfizer bid to beat Novo for Metsera, says BMO's Evan David Seigerman (CNBC TV)
05:08PM	Pfizer Responds to Delaware Chancery Court Ruling (Business Wire)
04:52PM	Pfizer Preps Improved Offer in Metsera Bidding War (The Wall Street Journal)
04:33PM	Earnings live: Snap stock soars, DoorDash tumbles, Qualcomm falls after one-time charge (Yahoo Finance)
04:33PM	Earnings live: Snap stock soars, DoorDash and Duolingo plunge in post-earnings swoon (Yahoo Finance)
04:31PM	Novo Nordisk CFO On Metsera, Hims And Lilly, And Why 'Hyper Growth' Has Stalled (Investor's Business Daily)
04:15PM	Moderna Is Running Low on Cash. Its Earnings Are Thursday. (Barrons.com)
03:54PM	FTC signals scrutiny of Novos bid for Metsera (BioPharma Dive)
02:02PM	Arvinas Inc (ARVN) Q3 2025 Earnings Call Highlights: Clinical Advancements and Strategic ... (GuruFocus.com)
11:41AM	Analyst Report: BioNTech SE (Morningstar Research)
10:43AM	Ozempic Maker Novo Nordisk Lowers Growth Outlook (The Wall Street Journal)
10:43AM	Novo Nordisk Stock Falls After Earnings. It Cut Guidance on These Fears. (Barrons.com)
08:19AM	Earnings live: AMD, Supermicro, and Novo Nordisk stocks fall, Pinterest tanks while Lemonade gets a boost (Yahoo Finance)
06:52AM	Loading…
06:52AM	Novo Nordisk and Pfizers bidding war for Metsera escalates despite legal threats (Pharmaceutical Technology)
06:48AM	The AI Stocks Selloff Could be a Bust or a Blip. This Will Decide Which. (Barrons.com)
06:47AM	Novo Nordisk Cuts Growth Outlook as Weight-Loss Drug Pressures Rise (GuruFocus.com)
05:00AM	Novo Nordisk Stock Up After Earnings. Guidance Cut on These Weight-Loss Drug Fears. (Barrons.com)
03:06AM	3 Magnificent Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 8.5% -- to Buy With Confidence in November (Motley Fool)
02:22AM	Google Clears DOJ Antitrust Hurdle for $32 Billion Wiz Deal (Bloomberg)
12:32AM	PFE Q3 Deep Dive: Pipeline, Cost Controls, and Business Development Shape Outlook (StockStory)
12:00AM	AP Top Financial News at 5:43 a.m. EST (Associated Press Finance)
12:00AM	AP Top Extended Financial Headlines at 5:43 a.m. EST (Associated Press Finance)
Nov-04-25 11:31PM	Michael Burry Is Super-Bearish On Palantir With 5 Million Puts (Benzinga)
06:52PM	Obesity Category Still Hot: Mizuho's Jared Holz (Bloomberg)
06:45PM	Stocks to Watch Tuesday: Palantir, Sarepta, Tesla (The Wall Street Journal)
05:10PM	Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup (The Wall Street Journal)
04:51PM	These Stocks Moved the Most Today: Palantir, Uber, Sarepta, Tesla, Norwegian Cruise Line, Hertz, AMD, and More (Barrons.com)
04:30PM	Novo Nordisk Reports Earnings on Wednesday. What to Expect. (Barrons.com)
04:27PM	Earnings live: Pinterest stock tanks, AMD and Supermicro falter, Rivian pops amid flurry of Q3 reports (Yahoo Finance)
04:18PM	Pfizer Hikes Earnings Outlook Even As Third-Quarter Sales Decline (Investor's Business Daily)
04:15PM	Analyst Report: Pfizer Inc. (Morningstar Research)
04:14PM	Pfizer Inc (PFE) Q3 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... (GuruFocus.com)
04:12PM	Novo Sweetens Its Bid For Metsera As Takeover Drama With Pfizer Escalates (Investor's Business Daily)
02:39PM	These Stocks Are Moving the Most Today: Palantir, Uber, Sarepta, Tesla, Norwegian Cruise Line, Hertz, AMD, and More (Barrons.com)
01:51PM	Analyst Report: Zoetis Inc. (Morningstar Research)
01:09PM	Pfizer and Novo Nordisk both raise bids for Metsera (CNBC TV)
12:59PM	Pfizer Stock Slips. Under the Surface, Earnings Werent Great. (Barrons.com)
12:26PM	Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera (Barrons.com)
11:18AM	Earnings Data Deluge (Zacks)
11:15AM	Pfizer Q3 Earnings Beat Estimates, Sales Decline as COVID Demand Cools (Zacks)
10:59AM	Pfizer & Novo boost Metsera bids, Hertz stock skyrockets (Yahoo Finance Video)
10:54AM	Pfizers Q3 Earnings Beat on Top and Bottom Lines (24/7 Wall St.)
10:47AM	Novo Sweetens Its Bid For Metsera, Pledging Up To $10 Billion (Investor's Business Daily)
10:38AM	Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer (Associated Press Finance)
10:35AM	Pre-markets Sell Off on No New Economic News (Zacks)
10:22AM	Novo, Pfizer Boost Metsera Bids in Obesity Startup Battle (Bloomberg)
10:05AM	Burry Reveals Nvidia and Palantir Puts After Bubble Warning (Bloomberg)
10:00AM	Here's What Key Metrics Tell Us About Pfizer (PFE) Q3 Earnings (Zacks)
09:58AM	Novo Nordisk Sweetens Offer for Metsera (The Wall Street Journal)
09:45AM	Pfizer COVID-19 vaccine sales tumble after government guidance on the shots narrows (Associated Press Finance)
09:30AM	Pfizer's revenue falls as COVID sales and vaccine recommendations continue to fade (MarketWatch)
09:12AM	Palantir's post-earnings drag, Uber sinks, Pfizer earnings (Yahoo Finance Video)
08:39AM	Pfizer's (NYSE:PFE) Q3 Earnings Results: Revenue In Line With Expectations (StockStory)
08:36AM	Should You Buy Moderna Stock Ahead of Q3 Earnings Report? (Zacks)
08:17AM	Michael Burry buys puts on Nvidia, Palantir (Investing.com)
08:17AM	Pfizer Raises Profit Outlook Even As Third-Quarter Sales Decline (Investor's Business Daily)
08:15AM	Earnings from Uber, Shopify, Spotify and Pfizer: Market Movers (Yahoo Finance Video)
08:06AM	Pfizer files second lawsuit against Metsera, Novo Nordisk (TipRanks)
08:00AM	Pfizer (PFE) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
07:53AM	Earnings live: Spotify stock jumps on strong results, Palantir and Uber stocks fall (Yahoo Finance)
07:37AM	Pfizer Stock Slips on Third-Quarter Earnings. What Covid-19 Has to Do With It. (Barrons.com)
07:35AM	Pfizer's $4.9 Billion Gamble: Inside Its Legal War to Reclaim the Obesity Market (GuruFocus.com)
07:20AM	Pfizer raises and narrows full-year earnings guidance (Investing.com)
07:04AM	Pfizer Profit Falls Amid Lower Covid-19 Drug Demand (The Wall Street Journal)
07:03AM	Pfizer: Q3 Earnings Snapshot (Associated Press Finance)
06:45AM	Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance (Business Wire)
05:31AM	These Stocks Are Moving the Most Today: Palantir, Sarepta, Amazon, AMD, Pfizer, and More (Barrons.com)
05:05AM	Uber and AMD headline Tuesday's earnings (MarketWatch)
04:30AM	Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? (Motley Fool)
04:29AM	Global Markets Fall After Fed Officials Express Diverging Views on Cuts (The Wall Street Journal)
04:13AM	McDonalds Earnings, Tariff Update, Musk Pay Vote: What to Watch This Week (The Wall Street Journal)
12:00AM	All megadeals lead to Washington (Financial Times)
Nov-03-25 07:00PM	AMD, Uber, Pfizer earnings on deck; ADP job data: What to Watch (Yahoo Finance Video)
06:17PM	Does the Market Have Bad Breadth? (Zacks)
04:32PM	Earnings live: Palantir stock rises modestly on strong results, Hims & Hers stock surges (Yahoo Finance)
04:11PM	Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. (Barrons.com)
01:23PM	Did Novo Nordisk Just Say "Checkmate" to Pfizer? (Motley Fool)
12:47PM	Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo (Investor's Business Daily)
12:15PM	Pfizer files second lawsuit to block Novo Nordisks $9bn Metsera bid (Financial Times)
12:03PM	Pfizer Aligns With Trump on Drug Pricing In Its Bid for Biotech Metsera (Barrons.com)
11:26AM	Stock Market Today: Stocks Rebound Midday After Amazon, Microsoft Announce New AI Deals (TheStreet)
11:13AM	Viking Therapeutics Could Be Pharmas Next Big Buyout Target (24/7 Wall St.)
11:06AM	Jim Cramer on Pfizer: "We'll Find Out if Pfizer's Going to Be More of a Stock and Less of a Bond Equivalent" (Insider Monkey)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM

TEM

Tempus AI Inc

PFE

Pfizer Inc

Upgrade your FINVIZ experience